$1.21 +0.02 (1.68%) Genetic Tech Shs Sponsored American Deposit Receipt Repr 150 Shs - NASDAQ

Dec. 9, 2016 | 03:59 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 1.21
Trade Time: Dec 09 03:59 PM Eastern Daylight Time
Change: +0.02 (1.68%)
Prev Close: 1.19
Open: 1.20
Bid: 1.21
Ask: 1.22
  1. Genetic Technologies Announces Settlement and Release Agreement With Hendrix Genetics

    Benzinga | Feb. 5, 2016 | 04:40AM EST
  2. Genetic Technologies Announces Publication of Key Scientific Validation Results in Support of ...

    GuruFocus | Dec. 21, 2015 | 23:06PM EST
  3. Genetic Technologies Announces Publication of Key Scientific Validation Results in Support of BREVAGenplus

    Benzinga | Dec. 21, 2015 | 05:48AM EST
  4. BREVAGenplus(R) Offers a Solution to Physicians Concerned About the Revised Breast Cancer Screening Guidelines from the American Cancer Society (ACS)

    Benzinga | Nov. 2, 2015 | 10:36AM EST
  5. Genetic Technologies Granted Key Patents by US Patent Office for BREVAGenplus(R)

    GuruFocus | Aug. 6, 2015 | 23:04PM EST
  6. Genetic Technologies Granted Key Patents by US Patent Office for BREVAGenplus

    Benzinga | Aug. 6, 2015 | 04:31AM EST
  7. Genetic Technologies Announces Scientific Validation, Clinical Trial and Peer Review ...

    GuruFocus | Jul. 14, 2015 | 23:02PM EST
  8. Morning Market Gainers

    Benzinga | Apr. 20, 2015 | 08:41AM EST
  9. Genetic Technologies Reports Additional Breast Health Centres to Begin Offering Brevagenplus

    Benzinga | Apr. 20, 2015 | 04:31AM EST
  10. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  11. Stock Futures Show Mild Losses; Boston Scientific Bolts Higher

    IBD | Feb. 18, 2015 | 09:16AM EST
  12. Morning Market Gainers

    Benzinga | Jan. 29, 2015 | 09:46AM EST
  13. Clinical Validation Study Supporting the Use of BREVAGenplus(R) in Breast Cancer Risk Assessment

    GuruFocus | Dec. 17, 2014 | 11:03AM EST
  14. Genetic Technologies Announces Clinical Validation Study Supporting the Use of BREVAGenplus in Breast Cancer Risk Assessment

    Benzinga | Dec. 17, 2014 | 05:56AM EST
  15. Genetic Technologies Launches BREVAGenplus(R) Breast Cancer Risk Assessment Test

    GuruFocus | Oct. 15, 2014 | 11:51AM EST
Trading Center